UMass Research May Lead to Non-Surgical Cataract Treatment
The University of Massachusetts Amherst recently licensed a new technology to Janssen Pharmaceuticals, Inc. that holds promise of revolutionizing the treatment of cataracts and presbyopia, based on early phase discoveries by polymer physicist Murugappan Muthukumar and former graduate student Ben Mohr regarding the fundamental science of proteins in the lens of the human eye.
New venture moves tunable nanogels toward commercialization
Cyta Therapeutics Inc., which Dr. Sankaran Thayumanavan cofounded in 2014 with Bonnie Fendrock and Steve Faraci, recently got a boost when the Mass Technology Transfer Center awarded Thayumanavan’s lab a $40,000 Innovation Commercialization Seed Fund grant.
7 Start-ups Formed in FY 2016, Compared to 2 in FY 2015!
Last summer, the TTO launched the “Envisioning Process” to encourage those interested in starting a company based on their inventions. In this process the TTO personally advises faculty and students about products and markets, how to incorporate, how to pick a name, how equity works and how to raise money, among other things. The goal is for the founders to say, “Hey, I can do that!” The TTO then commits to license the needed patent rights to the company.